Oestrogen plus progestogen v placebo (HT) for incidence of coronary heart disease (CHD) in postmenopausal women at mean 5.6 years*
| Outcomes | Annualised percentage developing CHD | Adjusted hazard ratio (95% CI) | |
|---|---|---|---|
| HT | Placebo | ||
| *MI = myocardial infarction. CI defined in glossary. Hazard ratio adjusted for the presence or absence of previous coronary revascularisation and sequential monitoring. | |||
| All CHD | 0.39% | 0.33% | 1.24 (0.97 to 1.60) |
| Nonfatal MI (including silent MI) | 0.31% | 0.25% | 1.28 (0.96 to 1.70) |
| Nonfatal MI (excluding silent MI) | 0.31% | 0.24% | 1.30 (0.97 to 1.74) |
| Death caused by CHD | 0.08% | 0.08% | 1.10 (0.65 to 1.89) |